☆ 4.8 News Item

COVID AND THE BRAIN: RESEARCHERS ZERO IN ON HOW DAMAGE OCCURS

NATURE (2021)

Related references

Note: Only part of the references are listed.
Article Immunology

High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms

Christiana Franke et al.

Summary: The study on critically ill COVID-19 patients presenting with unexplained neurological symptoms found that all patients showed anti-neuronal autoantibodies in serum or CSF, which may be related to clinical symptoms, particularly hyperexcitability. Several underlying autoantigens and their potential molecular mimicry with SARS-CoV-2 still need further identification.

BRAIN BEHAVIOR AND IMMUNITY (2021)

Add to Collection
Review Clinical Neurology

Neuropathogenesis of acute coronavirus disease 2019

Shelli F. Farhadian et al.

Summary: During the COVID-19 pandemic, it has been observed that SARS-CoV-2 infection may lead to neurological complications, with direct viral invasion of the central nervous system occurring only in a subset of cases. Vascular abnormalities and neuroimmune perturbations may contribute to neurological symptoms during acute infection, suggesting that immune-modulating interventions could be investigated to alleviate these complications and potentially impact long-term outcomes of COVID-19.

CURRENT OPINION IN NEUROLOGY (2021)

Add to Collection
Article Medicine, General & Internal

Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19-A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium

Sherry H. -Y. Chou et al.

Summary: This study included patients with clinically diagnosed or laboratory-confirmed COVID-19 at 28 centers across 13 countries and 4 continents from March 1 to September 30, 2020. Neurological manifestations were prevalent among hospitalized patients with COVID-19 and were associated with higher in-hospital mortality. Patients with preexisting neurological disorders were at increased risk of developing neurological signs and/or syndromes in COVID-19.

JAMA NETWORK OPEN (2021)

Add to Collection
Article Multidisciplinary Sciences

Dysregulation of brain and choroid plexus cell types in severe COVID-19

Andrew C. Yang et al.

Summary: This study found that patients with COVID-19 exhibited widespread cellular perturbations in the brain, including the relay of peripheral inflammation into the brain by choroid plexus barrier cells and infiltration of peripheral T cells. Additionally, COVID-19 affected synaptic signaling of upper-layer excitatory neurons linked to cognitive function.

NATURE (2021)

Add to Collection
Article Biochemistry & Molecular Biology

A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model

Jakob Kreye et al.

CELL (2020)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.